30 ML bupivacaine hydrochloride 7.5 MG/ML Injection [Marcaine]
- RxCUI
- 1724794
- RxNorm name
- 30 ML bupivacaine hydrochloride 7.5 MG/ML Injection [Marcaine]
- Display name
- MARCAINE (Injectable)
- Full name
- 30 ML bupivacaine hydrochloride 7.5 MG/ML Injection [Marcaine]
- Term type
- SBD
- Status
- Active
- Strength
- 7.5 mg/ml
- Dose form
- Injection 30 ml
- Route
- Injectable
- Updated
- 2026-10-27 17:49:03
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 012016
- Active start
- 012016
- Multiple ingredient
- NO
- Branded
- YES
Ingredients And Strength#
| Ingredient | Strength | Base | Basis of strength |
|---|---|---|---|
| bupivacaine hydrochloride | 7.5 MG / 1 ML | bupivacaine | bupivacaine hydrochloride |
Dose Form Concepts#
| Dose form | RxCUI |
|---|---|
| Injection | 1649574 |
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| bupivacaine | 1815 |
Source Vocabulary Codes#
| Code type | Values | Count | Category |
|---|---|---|---|
| PRESCRIBABLE | Y | 1 | ATTRIBUTES |
| RXNAV_STR | 30 ML Marcaine 7.5 MG/ML Injection | 1 | NAMES |
| RxNorm Name | 30 ML bupivacaine hydrochloride 7.5 MG/ML Injection [Marcaine] | 1 | NAMES |
| RxNorm Synonym | 3 | NAMES | |
| TTY | SBD | 1 | ATTRIBUTES |
| SPL_SET_ID | 67578b56-7540-487e-1fba-481255620e78 | 1 | CODES |
| RxCUI | 1724794 | 1 | CODES |
| MMSL_CODE | MTH_RXN_BD14936 | 1 | CODES |
FDA NDC Products And Packages#
| Package NDC | Product NDC | Name | Labeler | Application |
|---|---|---|---|---|
| 0409-2253-25 | 0409-2253 | Marcaine BUPIVACAINE HYDROCHLORIDE | Hospira, Inc. | NDA016964 |
Drugs@FDA Applications#
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Marcaine Spinal | BUPIVACAINE HYDROCHLORIDE IN DEXTROSE | Hospira, Inc. | 9679cc05-2f8a-4e88-53b5-6e9122c8b8c0 | 2026-06-23 | Warnings, Adverse reactions | 00409176119 00409176162 00409176118 00409176102 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 67578b56-7540-487e-1fba-481255620e78 | Marcaine 0.75 % in 30 ML Injection [PSN] · 30 ML bupivacaine hydrochloride 7.5 MG/ML Injection [Marcaine] [SBD] · 30 ML Marcaine 7.5 MG/ML Injection [SY] · Marcaine 0.75 % in 30 ML Injection [SY] · Marcaine 225 MG per 30 ML Injection [SY] | 5 | 38 | These highlights do not include all the information needed to use MARCAINE™ and MARCAINE™ WITH EPINEPHRINE safely and effectively. See full prescribing information for MARCAINE™ and MARCAINE™ WITH EPINEPHRINE. MARCAINE™ (bupivacaine hydrochloride) injection, for infiltration, perineural, caudal, epidural, or retrobulbar use MARCAINE™ WITH EPINEPHRINE (bupivacaine hydrochloride and epinephrine) injection, for infiltration, perineural, caudal, or epidural use Initial U.S. Approval: 1972 | 20260529 |
Recently Linked DailyMed Labels#
| Set ID | Title | Manufacturer | Effective |
|---|---|---|---|
| 9679cc05-2f8a-4e88-53b5-6e9122c8b8c0 | These highlights do not include all the information needed to use MARCAINE ® SPINAL safely and effectively. See full prescribing information for MARCAINE ® SPINAL. MARCAINE ® SPINAL (bupivacaine hydrochloride in dextrose injection) for subarachnoid injection Initial U.S. Approval: 1984 | Hospira, Inc. | Pfizer Healthcare India Private Limited | 20260623 |
| 9679cc05-2f8a-4e88-53b5-6e9122c8b8c0 | These highlights do not include all the information needed to use MARCAINE ® SPINAL safely and effectively. See full prescribing information for MARCAINE ® SPINAL. MARCAINE ® SPINAL (bupivacaine hydrochloride in dextrose injection) for subarachnoid injection Initial U.S. Approval: 1984 | Hospira, Inc. | Pfizer Healthcare India Private Limited | 20250513 |
| b32ea505-8712-4b65-947e-b774252b93ed | Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc. | 20200316 | |
| f7f423ac-9328-428a-9358-a49100935803 | Smiths Medical ASD, Inc. | Hospira, Inc. | 20161103 | |
| 8d27e3a8-292f-4afb-9277-03bce380364c | Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc. | 20161017 | |
| e877d058-1bbe-4171-bd57-3fd3e849de5c | Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc. | 20161013 | |
| a2f89908-ee69-4d79-9c95-9725985f16d5 | Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc. | 20161003 | |
| a0a773ce-d637-436f-8f17-a867b285f8ed | Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc. | 20160929 | |
| 891e910b-17de-4ab8-a79b-e092e8641fa6 | Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc. | 20160928 | |
| 8801fbd4-ff09-4aec-a41f-9ff5883c246f | Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc. | 20160928 | |
| e95b8043-e5e9-478a-8993-f30b3c8edf5a | Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc. | 20160906 | |
| af0d2b6a-6a44-4d8e-87b1-29a3ee1ff805 | Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc. | 20160831 | |
| f04a27be-c2a4-4058-81d2-528782be6d2d | Smiths Medical ASD, Inc. | Hospira, Inc. | Kwang Myung Pharm. Co., Ltd. | Aplicare, Inc. | 20160620 | |
| 7ed96d02-ca26-430b-bdb5-634d8b088226 | Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc. | 20160520 | |
| fdad4127-3458-498c-8674-439eab28a0fc | Smiths Medical ASD, Inc. | Hospira, Inc. | 20160427 | |
| 9a127754-0b0e-44ac-953a-0685a8b7b175 | Smiths Medical ASD, Inc. | Hospira, Inc. | 20151229 | |
| 70e2c96a-9284-40b2-8271-79f3a8dada53 | Smiths Medical ASD, Inc. | Hospira, Inc. | 20150630 | |
| acd082d1-c167-4350-b3f2-6b8384d25140 | Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc. | 20150612 | |
| 733b51c6-1128-4eaf-8ebb-722c7cc7eb0a | Smiths Medical ASD, Inc. | Hospira, Inc. | 3M Company | 20150528 | |
| d03c6758-2e38-4777-bb3b-c0f5b077e4b8 | Smiths Medical ASD, Inc. | Hospira, Inc. | 3M Company | 20150219 | |
| d35a9f96-a0db-4060-9f9d-ba2117288fd0 | Smiths Medical ASD, Inc. | Hospira, Inc. | 3M Company | 20150218 | |
| bd8075e4-9dff-48a5-bd36-659d926c7735 | Smiths Medical ASD, Inc. | Hospira, Inc. | 3M Company | 20150218 | |
| fc5b6260-09c4-4522-bddf-b93d5a2d02e5 | Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc. | 3M Company | 20150211 | |
| bfd25295-4ae5-4f37-916d-752d269682e4 | Smiths Medical ASD, Inc. | Hospira, Inc. | 20141017 | |
| a7ba3956-f343-4a8c-8ad4-3dc20342e16d | Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc. | 20140820 | |
| f7abd8c3-4a29-4416-b5e2-153d49b802d9 | Smiths Medical ASD, Inc. | Hospira, Inc. | Kwang Myung Pharm. Co., Ltd. | Aplicare, Inc. | 20130904 | |
| 969d14d0-3df1-4cae-ac79-59b535cecfb4 | Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc. | Kwang Myung Pharm. Co., Ltd. | 20121116 | |
| f05b2042-3183-486f-bf69-409acf87e6ab | Smiths Medical ASD, Inc. | Hospira, Inc. | Kwang Myung Pharm. Co., Ltd. | Aplicare, Inc. | 20121115 | |
| cb41de08-0381-4f6f-bcd4-95feda248dac | Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc. | 20121101 | |
| 980692b6-5e76-4276-aae0-628f2759e479 | Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc. | 20120904 | |
| 984668f0-4061-412d-9f39-62b33ea4a77e | Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc. | 20120904 | |
| a036507c-a4c2-4774-b4f5-617fcaf12b87 | National Council for Prescription Drug Programs | 20120724 | |
| eea7b068-06d4-4a04-8a8a-20b3812561c8 | Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc. | 20120625 | |
| e8240633-04c4-4789-9b64-f11b319c6a8a | Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc. | 20120622 | |
| f7dcea2d-0dd4-48e6-9c7f-762331088298 | Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc. | 20120614 | |
| f0456563-acf1-4643-823a-2517e87adf49 | Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc. | 20120612 | |
| f9609aa3-cba3-4478-bf77-22d594ecd728 | Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc. | 20120404 | |
| 74df795f-0a99-42f9-a604-e0fed5ae2b71 | Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc. | 20120403 | |
| 8a010871-9422-4bf7-87f7-5850b70a554a | Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc. | 20120402 | |
| 7922bef8-466c-4e27-921b-4bc7032ed3ed | Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc. | 20120308 |
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | N01BB | Amides | ATC1-4 | bupivacaine | |
| FDASPL | D000577 | Amides | CHEM | has_chemical_structure | bupivacaine |
| FDASPL | N0000175682 | Amide Local Anesthetic | EPC | has_epc | bupivacaine |
| FDASPL | N0000175976 | Local Anesthesia | PE | has_pe | bupivacaine |
| MEDRT | D002045 | Bupivacaine | CHEM | has_ingredient | bupivacaine |
| MEDRT | D002045 | Bupivacaine | CHEM | has_ingredient | bupivacaine hydrochloride |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | bupivacaine |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | bupivacaine hydrochloride |
| MEDRT | D010146 | Pain | DISEASE | may_prevent | bupivacaine |
| MEDRT | D010146 | Pain | DISEASE | may_prevent | bupivacaine hydrochloride |
| MEDRT | D010149 | Postoperative Pain | DISEASE | may_treat | bupivacaine |
| MEDRT | D010149 | Postoperative Pain | DISEASE | may_treat | bupivacaine hydrochloride |
| MEDRT | N0000000108 | Prostaglandin Receptor Antagonists | MOA | has_moa | bupivacaine |
| MEDRT | N0000000108 | Prostaglandin Receptor Antagonists | MOA | has_moa | bupivacaine hydrochloride |
| MEDRT | N0000000180 | Sodium Channel Interactions | MOA | has_moa | bupivacaine |
| MEDRT | N0000000180 | Sodium Channel Interactions | MOA | has_moa | bupivacaine hydrochloride |
| MEDRT | N0000008768 | Decreased Organized Electrical Activity | PE | has_pe | bupivacaine |
| MEDRT | N0000008768 | Decreased Organized Electrical Activity | PE | has_pe | bupivacaine hydrochloride |
| MEDRT | N0000175976 | Local Anesthesia | PE | has_pe | bupivacaine hydrochloride |
| MEDRT | N0000175976 | Local Anesthesia | PE | has_pe | bupivacaine |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | AVAILABLE_STRENGTH | 7.5 MG/ML |
| ATTRIBUTES | GENERAL_CARDINALITY | SINGLE |
| ATTRIBUTES | HUMAN_DRUG | US |
| ATTRIBUTES | QUANTITY | 30 ML |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| ATTRIBUTES | SCHEDULE | 0 |
| CODES | NDA | NDA016964 |
| NAMES | Prescribable Synonym | Marcaine 0.75 % in 30 ML Injection |
| NAMES | Tallman Synonym | 30 ML BUPivacaine hydrochloride 7.5 MG/ML Injection [Marcaine] |
| SOURCES | Source | Gold Standard Alchemy |
| SOURCES | Source | Metathesaurus FDA Structured Product Labels |
| SOURCES | Source | Micromedex RED BOOK |
| SOURCES | Source | Multum MediSource Lexicon |